Encouraging outcomes from a clinical study on the LSD-analog substance MM120, or lysergide d-tartrate, have led the Food and Drug Administration (FDA) to designate it as a “breakthrough therapy” for ...

Scientists have long known that psychedelics like LSD can help the brain grow new connections. These drugs promote something called neuroplasticity, which helps the brain heal from mental illness. But ...

March 7 (UPI) --A psychedelic medicine biotech company announced Thursday its LSD-based drug has won U.S. Food and Drug Administration breakthrough treatment status for treating generalized anxiety ...

A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...

LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...

WASHINGTON – LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in ...

A cortical neuron treated with JRT, a synthetic molecule similar to the psychedelic drug LSD. Drugs like JRT might enable new treatments for conditions such as schizophrenia, without the ...

Read full article: Kissimmee businesses encourage membership in neighborhood watch-style safety coalition Family of Salaythis Melvin files federal lawsuit against Orange County Sheriff’s Office Read ...

University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic’s therapeutic power with reduced hallucinogenic ...

WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...